# Ketone Esters Blunt Inflammaging: Selective Suppression of Age-Associated B Cells Preserves Immune Competence **URL:** \ **Category:** News\ **Created:** [November 6, 2026, 7:25am UTC](https://www.rapamycin.news/t/ketone-esters-blunt-inflammaging-selective-suppression-of-age-associated-b-cells-preserves-immune-competence/27368 "2026-11-06T07:25:51Z")\ **Posts on this page:** 2\ **Page:** 1
**Author:** ![RapAdmin](https://www.rapamycin.news/user_avatar/www.rapamycin.news/rapadmin/32/377_2.png) [@RapAdmin](https://www.rapamycin.news/u/RapAdmin)\ **Post date:** [November 6, 2026, 7:25am UTC](https://www.rapamycin.news/t/ketone-esters-blunt-inflammaging-selective-suppression-of-age-associated-b-cells-preserves-immune-competence/27368/1 "2026-11-06T07:25:52Z")
![ketoneInflammation-2](https://www.rapamycin.news/uploads/default/original/3X/0/0/00c3abeecb974217da31dbc394532dc4931fbfe0.jpeg) **Aging is characterized by a progressive decline in immune function and a simultaneous increase in chronic, low-grade inflammation, largely driven by the accumulation of age-associated B cells. These cells contribute to autoimmune pathology by secreting pro-inflammatory cytokines and autoantibodies. This preclinical murine study investigated the immunomodulatory effects of a 15-week dietary intervention using the ketone ester bis-octanoyl (R)-1,3-butanediol. The dietary supplementation significantly increased circulating beta-hydroxybutyrate levels and suppressed the baseline activation of age-associated B cells in the spleen. Crucially, this metabolic intervention downregulated key inflammatory transcription factors and translation pathways without impairing the generation of antigen-specific antibodies following active immunization. The findings present a targeted metabolic strategy to separate pathological immune overactivation from necessary adaptive immune responses during biological aging.** The aging immune system presents a paradoxical challenge characterized by immunosenescence (the inability to mount effective responses to novel pathogens or vaccines) and inflammaging (chronic, systemic hyperactivation that damages native tissues). A primary driver of this dysfunction is the accumulation of age-associated B cells. In youth, these cells constitute approximately 5% of the splenic B cell population, but they expand nearly five-fold by late life, aggressively secreting pro-inflammatory mediators and autoantibodies that fuel degenerative pathologies. While severe dietary interventions like prolonged fasting or strict ketogenic diets have shown efficacy in blunting this inflammatory cascade, compliance among older human populations remains exceedingly poor due to physical and metabolic demands. Exogenous ketone supplementation offers a bypass mechanism to achieve therapeutic circulating ketone levels without requiring absolute carbohydrate restriction. Researchers at the Buck Institute for Research on Aging utilized the specific ketone ester bis-octanoyl (R)-1,3-butanediol to evaluate its impact on the aged immune landscape. Over a 15-week period, aged mice provided with the ketone ester diet demonstrated a highly specific phenotypic shift in their immune architecture. The intervention selectively downregulated activation markers (CD69 and CD95) on age-associated B cells while reducing their dependence on glucose metabolism. This effect is mediated by the signaling properties of beta-hydroxybutyrate, which acts directly on these cells to suppress the mTORC1 signaling pathway, thereby reducing abnormal cellular translation and halting the overexpression of T-bet, the master transcription factor responsible for the autoimmune behavior of age-associated B cells. The most critical finding from a clinical and biohacking perspective is the precise selectivity of this intervention. Broad immunosuppressants typically resolve inflammaging at the cost of rendering the subject highly vulnerable to infection. However, when the ketone ester-treated mice were actively challenged with an immunization protocol, their adaptive immune systems successfully mounted a robust, high-affinity antibody response equivalent to that of the control group. This indicates that ketone esters do not universally cripple the immune system. Instead, they specifically quiet the baseline “noise” of chronic inflammation while leaving the functional machinery required for acute pathogenic defense entirely intact. This selective immunomodulation validates exogenous ketones as a highly pragmatic tool for managing the aging phenotype. ### Actionable Insights The continuous oral consumption of bis-octanoyl (R)-1,3-butanediol can elevate systemic beta-hydroxybutyrate to immunomodulatory levels without the need for strict ketogenic fasting protocols. For individuals focused on longevity, this suggests that incorporating specific exogenous ketone esters may successfully suppress chronic inflammatory pathways driven by senescent immune cells. The practical magnitude of this intervention is notable. The dietary protocol successfully elevated circulating R-beta-hydroxybutyrate from near-zero baseline levels to a sustained range of 0.5 to 1.0 mM (an absolute increase reflecting a massive relative shift in metabolic environment). Consequently, flow cytometry data indicated significant reductions in CD69 and CD95 activation markers across the age-associated B cell population (p-values ranging from 0.001 to 0.028, representing robust statistical significance despite a small sample size of N=8 per group). The transition to a ketone-enriched state resulted in a measurable decrease in cellular glucose dependence and suppressed the mTOR-driven translation responsible for aberrant protein synthesis. For those aiming to mitigate autoimmune tendencies as they age, targeting a daily circulating beta-hydroxybutyrate level approaching 1.0 mM via ester supplementation represents a practical mechanism to blunt systemic inflammatory signals while preserving acute immune reactivity. ### Context/Source - **Open Access Paper:** [Ketone ester supplementation reduces age-associated B cell activation in aged mice without impairing antibody responses](https://doi.org/10.21203/rs.3.rs-10756850/v1), September 3rd, 2026. - **Institution:** Buck Institute for Research on Aging - **Country:** United States - **Journal Name:** Research Square (Preprint Server) - **Impact Evaluation:** The impact score of this journal is 0 (as it is a preprint repository, not a peer-reviewed journal) ---
**Author:** ![RapAdmin](https://www.rapamycin.news/user_avatar/www.rapamycin.news/rapadmin/32/377_2.png) [@RapAdmin](https://www.rapamycin.news/u/RapAdmin)\ **Post date:** [November 6, 2026, 7:32am UTC](https://www.rapamycin.news/t/ketone-esters-blunt-inflammaging-selective-suppression-of-age-associated-b-cells-preserves-immune-competence/27368/2 "2026-11-06T07:32:02Z")
### Biomarker Data (Effect Size Calculation) Lifespan extension metrics are not applicable. The primary biomarker modifications occurred within cellular immunometabolism. 1. **Systemic Ketosis (R-BHB Levels):** The ketone ester diet produced a sustained absolute increase in circulating R-beta-hydroxybutyrate from near 0 mM to an average peak range of 0.5 mM to 1.0 mM. Given the near-zero baseline in standard high-carbohydrate murine diets, this represents an infinite relative percentage increase and establishes a robust metabolic foundation for systemic signaling alterations. 2. **Cellular Activation Markers:** The intervention significantly reduced the absolute count and relative proportion of hyperactivated age-associated B cells. Although raw numerical tables were not provided to calculate precise Cohen’s d values, the reported likelihood ratio tests for suppression of CD69, CD95, CD11c, and CD138 activation markers yielded statistically robust p-values (p \< 0.05 to p = 0.001) in small cohorts (N=8), strongly suggesting a large standardized effect size (Cohen’s d \> 0.8). 3. **Metabolic Reprogramming:** Ex vivo SCENITH assays demonstrated a reduction in glucose dependence among CD11b+CD11c+ B cells. Furthermore, exogenous beta-hydroxybutyrate treatment aggressively diminished phosphorylated S6 (pS6) expression, indicating marked inhibition of the mTORC1 pathway. ### Novelty Prior literature extensively documents the benefits of fasting and ketogenic diets on innate immune cells (macrophages) and the NLRP3 inflammasome. This paper fundamentally advances the field by demonstrating that exogenous ketone bodies act directly on the adaptive immune system (specifically B lymphocytes) to suppress translation and activation in the context of biological aging, selectively targeting senescent cell populations without inducing widespread immunodeficiency.